The Auto Channel
The Largest Independent Automotive Research Resource
The Largest Independent Automotive Research Resource
Official Website of the New Car Buyer

Teleflex Reports Third Quarter 2002 Results: Revenues Increased 9%; Net Income Up 19%

    PLYMOUTH MEETING, Pa.--Oct. 16, 2002--Teleflex Incorporated today reported revenues in the third quarter ended September 29, 2002 increased 9% to $508.2 million compared to $466.0 million for the year-ago quarter. Net income in the quarter was $26.3 million and diluted earnings per share were 66 cents. Results included a benefit from income tax settlements which contributed $3.1 million to net income, or 8 cents per diluted share in the third quarter.
    Revenues in the first nine months of 2002 increased 9% to $1.6 billion compared to $1.4 billion last year. Net income in the first nine months, including the tax settlements, was $90.2 million compared to $83.1 million for the same period in 2001. Diluted earnings per share increased to $2.27 compared to $2.12 per share for the same period a year ago.
    Jeffrey P. Black, president and chief executive officer, said, "Strong volume gains this quarter in our Commercial Segment businesses coupled with increased sales in our Medical Segment offset a decline in demand for Aerospace products and services. We see these trends continuing into the final quarter of the year, and, as a result, we now anticipate that earnings for 2002 will be in the range of $3.10 per share. Cash flow from operations in the first nine months was $151 million, well ahead of last year."
    The Commercial Segment reported a 20% increase in sales in the quarter with gains in all three product lines, Automotive, Marine and Industrial, as a result of strong market demand and new products. These businesses account for 52% of total corporate revenues. Operating profits grew as a result of higher volumes.
    Medical Segment sales increased 7% in the third quarter. Operating profit improved slightly as gains in the Hospital Supply product line more than compensated for unfavorable product mix in the Surgical Devices product line. Medical represents 22% of total corporate revenues.
    Aerospace Segment sales declined 7% in the quarter reflecting ongoing weakness in both the commercial aerospace and the industrial gas turbine markets. Sales were down in all four product lines, as demand from OEM and aftermarket customers continued to be soft. Operating profit fell sharply as a result of pricing pressure and the lower sales volume.
    In accordance with the adoption of SFAS 142, Teleflex stopped amortizing goodwill as of December 31, 2001. Excluding goodwill amortization in the third quarter of 2001, net income improved 7% compared to the third quarter of last year and diluted earnings per share increased 6%. To facilitate comparisons of segment operating results, prior year goodwill amortization in the accompanying financial summary has been reclassified as a corporate rather than a segment expense. Goodwill amortization expense in the third quarter of 2001 was $3.2 million pre-tax, or 6 cents per share after tax. The pre-tax impact on third quarter 2001 operating earnings by segment is as follows: Commercial $740,000; Medical $2,142,000; Aerospace $347,000.
    As previously announced, Teleflex will comment on third quarter 2002 results on a conference call to be held Thursday, October 17th, at 11:15 a.m. (ET). The call can be accessed by dialing (888) 634-9566, or by logging on to the company's website at www.teleflex.com. The figures are as follows:




             COMPARATIVE SUMMARY OF REVENUES AND EARNINGS
                              (Unaudited)

                                                               Percent
Three Months Ended     September 29, 2002  September 30, 2001   Change

Sales
  Commercial Products      $262,116,000        $218,253,000       20%
  Medical Products          112,223,000         104,537,000        7%
  Aerospace Products        133,899,000         143,224,000       (7%)
                            -----------         -----------
               Total       $508,238,000        $466,014,000        9%

Operating Profit
  Commercial Products       $18,742,000         $14,788,000       27%
  Medical Products           17,617,000          17,380,000        1%
  Aerospace Products          7,954,000          15,396,000      (48%)
                              ---------          ----------
               Total        $44,313,000         $47,564,000(1)    (7%)

Less:
 Interest expense             6,280,000           7,263,000      (14%)
 Corporate expenses           4,893,000           4,807,000        2%
 Goodwill amortization              ---           3,229,000(1)     --
                             ----------           ---------
Income before taxes          33,140,000          32,265,000        3%
Taxes on income               6,860,000          10,163,000      (33%)
                              ---------          ----------
Net income                  $26,280,000         $22,102,000       19%
                            ===========         ===========

Earnings per share
  Basic                            $.67                $.57       18%
  Diluted                          $.66                $.56       18%
Average shares outstanding
  Basic                      39,341,000          38,847,000
  Diluted                    39,820,000          39,379,000

                                                               Percent
Nine Months Ended      September 29, 2002   September 30, 2001  Change

Sales
  Commercial Products      $819,516,000        $687,669,000       19%
  Medical Products          332,999,000         318,307,000        5%
  Aerospace Products        410,425,000         433,776,000       (5%)
                            -----------         -----------
               Total     $1,562,940,000      $1,439,752,000        9%

Operating Profit
  Commercial Products       $74,130,000         $66,496,000       11%
  Medical Products           53,378,000          52,113,000        2%
  Aerospace Products         30,271,000          48,267,000      (37%)
                            -----------         -----------
               Total       $157,779,000        $166,876,000(1)    (5%)

Less:
  Interest expense           18,555,000          21,352,000      (13%)
  Corporate expenses         14,076,000          14,100,000        --
  Goodwill amortization             ---           9,657,000(1)     --
                            -----------           ---------
Income before taxes         125,148,000         121,767,000        3%
Taxes on income              34,914,000          38,623,000      (10%)
                             ----------          ----------
Net income                  $90,234,000         $83,144,000        9%
                            ===========         ===========

Earnings per share
  Basic                           $2.30               $2.15        7%
  Diluted                         $2.27               $2.12        7%
Average shares outstanding
  Basic                      39,207,000          38,700,000
  Diluted                    39,809,000          39,258,000


(1) Goodwill amortization in 2001 has been reclassified from operating
    profit to a corporate expense item to facilitate comparison with
    the current period's operating results.


                               CONDENSED CONSOLIDATED BALANCE SHEET
                                            (Unaudited)

                       September 29, 2002    December 30, 2001
Assets
Current assets
  Cash and cash
   equivalents              $54,429,000         $46,900,000
  Accounts
   receivable, net          398,411,000         363,674,000
Inventories                 363,006,000         308,775,000
Prepaid expenses             25,121,000          28,128,000
                             ----------          ----------
                            840,967,000         747,477,000

Property, plant and
 equipment, net             591,465,000         565,695,000
Goodwill                    249,130,000         223,911,000
Intangibles and
 other assets                69,378,000          56,444,000
Investments in
 affiliates                  44,758,000          41,493,000
                             ----------          ----------
                         $1,795,698,000      $1,635,020,000
                         ==============      ==============

Liabilities and
 shareholders' equity
Current liabilities
   Current borrowings      $232,855,000        $212,122,000
   Accounts payable
    and accrued expenses    274,830,000         251,805,000
   Income taxes payable      45,917,000          31,499,000
                             ----------          ----------
                            553,602,000         495,426,000

Long-term borrowings        220,414,000         228,180,000
Deferred income taxes
 and other                  145,735,000         133,271,000
                            -----------         -----------
                            919,751,000         856,877,000

Shareholders' equity        875,947,000         778,143,000
                            -----------         -----------
                         $1,795,698,000      $1,635,020,000
                         ==============      ==============



    Teleflex At A Glance:

    Teleflex is a diversified industrial company with annual revenues of approximately $2 billion. The company designs, manufactures and distributes quality engineered products and services for the aerospace, medical, automotive, marine and industrial markets worldwide. Teleflex employs more than 17,000 people worldwide who focus on providing innovative solutions for customers. Additional information about Teleflex, including a recent archived conference call with analysts and investors, can be obtained from the company's Web site on the Internet at www.teleflex.com.

    Forward-looking information:

    Statements in this news release, other than historical data, are considered forward-looking statements under the Private Securities Litigation Reform Act of 1995. These statements are subject to various risks and uncertainties that may cause actual results to differ from those contemplated in the statements. These factors are discussed in the company's Securities and Exchange Commission filings.